Artivion, Inc. Common Stock AORT 深 沪
等待开盘 12-18 09:30:00 美东时间
47.18
+1.270
+2.77%
华盛通- 最 高48.25
- 今 开45.77
- 成交量 67.29万股
- 最 低 45.77
- 昨 收 45.91
- 总市值 22.26亿
- 52周最高 48.25
- 市盈率 静 --
- 换手率 1.43%
- 52周最低 21.97
- 委 比 33.33%
- 总股本 4718.37万
- 历史最高 48.25
- 量 比 1.95
- 振 幅 5.40%
- 历史最低 3.82
- 每 手 1
- 风险率 7.81%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
11-10 17:17
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
11-10 10:22
Artivion Q3 Adj. EPS $0.16, Sales $113.388M Beat $110.437M Estimate
Artivion (NYSE:AORT) reported quarterly earnings of $0.16 per share which beat the analyst consensus estimate of $0.02 by 841.18 percent. This is a 33.33 percent increase over earnings of $0.12 per share from the same
11-07 05:34
Artivion Treats First Patient In ARTIZEN Pivotal Study Evaluating Arcevo LSA Hybrid Stent Graft System For Acute, Chronic Arch Pathologies
Artivion, Inc. (NYSE:AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced the treatment of the first patient in the ARTIZEN pivotal trial, evaluating the safety and
11-06 21:36
Earnings Scheduled For November 6, 2025
Companies Reporting Before The Bell • Clear Channel Outdoor (NYSE:CCO) is expec...
11-06 19:12
Earnings Preview For Inspire Medical Systems
Inspire Medical Systems (NYSE:INSP) is gearing up to announce its quarterly ear...
11-01 01:02
美股大行评级 | 伯恩斯坦上调阿里巴巴目标价升至200美元；麦格理上调百度评级至"跑赢大市"，目标价升至176美元
今日重点评级关注：摩根大通：维持National Energy Services"超配"评级，目标价从10美元升至19美元；Piper Sandler：维持LENZ Therapeutics"超配"评级，目标价从51美元升至67美元
10-13 11:26
JMP Securities Maintains Market Outperform on Artivion, Raises Price Target to $47
JMP Securities analyst Daniel Stauder maintains Artivion (NYSE:AORT) with a Market Outperform and raises the price target from $42 to $47.
10-10 21:01
美股大行评级 | 潜在涨幅207.38%！GoldMining获HC Wainwright升目标价至3.75美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持GoldMining"买入"评级，目标价从3.25美元升至3.75美元；摩根士丹利：维持Crinetics Pharmaceuticals"超配"评级，目标价从65美元升至77美元
09-30 14:16
Artivion To Acquire 1300 East Anderson Lane Property For $12.05M And 1200 East Anderson Lane Property For $8.45M
On September 26, 2025, Artivion, Inc. (the "Company") entered into two Real Estate Purchase and Sale Contracts having substantially similar material terms, except as noted otherwise herein. The first agreement is
09-30 04:48
